K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers

International Journal of Pancreatology

Volumn 21, Issue 3, 1997, Pages 205-217

  Sugio, Kenji ^a   Molberg, Kyle ^b   Albores Saavedra, Jorge ^c   Virmani, Arvind K ^a   Kishimoto, Yosuke ^a   Gazdar, Adi F ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Division of Anatomic Pathology   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

18q; 5q; K ras; Pancreatic cancer; Preneoplastic lesions

Indexed keywords

ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CHROMOSOME 18Q; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; EARLY DIAGNOSIS; GENE LOSS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; ONCOGENE K RAS; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 0030856052     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02821606     Document Type: Article

References (45)

1. Warshaw AL, CastilloCF-D. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-465.
2. Albores-Saavedra J, Vuitch F, Henson DE. Exocrine pancreas, in: Pathology of Incipient Neoplasia. Henson DE, Albores-Saavedra J, eds: W. B. Saunders, Philadelphia, 1993; pp. 182-190.
3. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-4689.
4. Almoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549-554.
5. Hohne MW, Halatsch ME, Kahl GF, et al. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 1992; 52: 2616-2619.
6. Horii A, Nakatsuru S, Miyoshi Y, et al. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 1992; 52: 6696-6698.
7. Scarpa A, Capelli P, Mukai K, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 1993; 142: 1534-1543.
8. Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994; 54: 1556-1560.
9. Hruban RH, van Mansfeld AD, Offerhaus GJ, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase 18 chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993; 143: 545-554.
10. Oreffo VI, Lin HW, Padmanabhan R, et al. K-MS and p53 point mutations in 4-(methylnitrosamino)-1 -(3-pyridyl)-1-butanoneinduced hamster lung tumors. Carcinogenesis 1993; 14:451-55.
11. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-669.
12. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-665.
13. Mitsudomi T, Viallet J, Mulshine JL, et al. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene 1991; 6: 1353-1362.
14. Seymour AB, Hruban RH, Redston M, et al. Allelotype of pancreatic adenocarcinoma. Cancer Res 1994; 54: 2761-2764.
15. Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 199S; 273: 558-563.
16. Sugio K, Kishimoto Y, Virmani AK, et al. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 1994; 54: 5811-5815.
17. Whetsell L, Maw G, Nadon N, et al. Polymerase chain reaction microanalysis of tumors from stained histological slides. Oncogene 1992; 7: 2355-2361.
18. Spirio L, Nelson L, Ward K, et al. A CA-repeat polymorphism close to the adenomatous polyposis cold (APC) gene offers improved diagnostic testing for familial APC. Am J Hum Genet 1993; 52: 286-296.
19. Risinger JI, Boyd J. Dinucleotide repeat polymorphism in the human DCC gene at chromosome 18q21. Hum Mol Genet 1992; 1:657.
20. Jiang W, Kahn SM, Guillem JG, et al. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene 1989; 4: 923-928.
21. Hand HJ, Todd AV. Estimation of the proportions of mutant and normal N-ras alleles by allele specific restriction analysis. Nucleic Acids Res 1992; 20: 620.
22. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49: 3713-3721.
23. Kozuka S, Sassa R, Taki T, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979; 43: 1418-1428.
24. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
25. Sasaki H, Nishii H, Takahashi H, et al. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res 1993; 53: 1906-1910.
26. Duggan BD, Felix JC, Muderspach LI, et al. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. Cancer Res 1994; 54: 1604-1607.
27. TabataT,FujimoriT,MaedaS,etal.Theroleof/tesmutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis./JPancreatol 1993; 14: 237-244.
28. Lemoine NR, Jain S, Hughes CM, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992; 102:230-236.
29. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993; 53: 953-956.
30. DiGiuseppe JA, Hruban RH, Offerhaus GJ, et al. Detectionof K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma [see comments]. Am J Patliol 1994; 144: 889-895.
31. Caldas C, Hahn SA, Hruban RH, et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocar-cinoma and pancreatic ductal hyperplasia. Cancer Res 1994; 54: 3568-3573.
32. Ekbom A, McLaughlin JK, Karlsson BM, et al. Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst 1994; 86: 625-627.
33. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1954; 6: 963-968.
34. Grunewald K, Lyons J, Frohlich A, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989; 43: 1037-1041.
35. Motojima K, Urano T, Nagata Y, et al. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993:217:138-143.
36. van Heerden JA, ReMine WH, Weiland LH, et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas: Mayo Clinic experience. Am J Surg 1981; 142:308-311.
37. Ihse I, Lilja P. Arnesjo B. et al. Total pancreatectomy for cancer. An appraisal of 65 cases. Ann Surg 1977; 186:675-680.
38. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease [see comments]. Gastroenterology 1996; 110: 227-231.
39. Finney RE, Bishop JM. Predisposition to neoplastic transformation caused by gene replacement of H-rasl. Science 1993; 260: 1524-1527.
40. Parada LF, Land H, Weinberg RA, et al. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 1984; 312: 649-651.
41. McKie AB, Filipe MI, Lemoine NR. Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer. Int J Cancer 1993; 55: 598-603.
42. Hahn SA, Hoque AT, Moskaluk ÇA, et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 1996; 56: 490-494.
43. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. [see comments]. Science 1996; 271: 350-353.
44. Cho KR, Vogelstein B. Genetic alterations in the adenoma-carcinoma sequence. Cancer 1992; 70s: 1727-1731.
45. Urban T, Ricci S, Grange JD, et al. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas [see comments]. J Natl Cancer Inst 1993; 85: 2008-2012.